PMGC Holdings Inc. (NASDAQ:ELAB) Sees Large Drop in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totaling 236,186 shares, a decrease of 43.0% from the April 15th total of 414,506 shares. Based on an average daily trading volume, of 1,987,934 shares, the days-to-cover ratio is presently 0.1 days. Approximately 20.4% of the company’s shares are short sold.

PMGC Stock Up 1.0%

NASDAQ:ELAB traded up $0.02 during trading hours on Friday, reaching $2.08. The company had a trading volume of 1,622,509 shares, compared to its average volume of 1,436,766. The company has a quick ratio of 1.72, a current ratio of 1.74 and a debt-to-equity ratio of 0.01. The firm has a market cap of $2.41 million, a price-to-earnings ratio of -0.01 and a beta of -0.27. The business’s 50-day simple moving average is $3.70 and its two-hundred day simple moving average is $41.87. PMGC has a twelve month low of $1.62 and a twelve month high of $309.12.

PMGC (NASDAQ:ELAB) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($11.22) EPS for the quarter. The business had revenue of $0.68 million for the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.